Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 67
Number of items: 67
  • Zamani, Y., Mohammadi, J., Amoabediny, G., Visscher, D. O., Helder, M. N., Zandieh-Doulabi, B., & Klein-Nulend, J. (2019). Enhanced osteogenic activity by MC3T3-E1 pre-osteoblasts on chemically surface-modified poly(ϵ-caprolactone) 3D-printed scaffolds compared to RGD immobilized scaffolds. Biomedical Materials (Bristol), 14(1), Article 015008. https://doi.org/10.1088/1748-605X/aaeb82
  • Open Access
    Tabeian, H., Betti, B. F., dos Santos Cirqueira, C., de Vries, T. J., Lobbezoo, F., ter Linde, A. V., Zandieh-Doulabi, B., Koenders, M. I., Everts, V., & Bakker, A. D. (2019). IL-1β Damages Fibrocartilage and Upregulates MMP-13 Expression in Fibrochondrocytes in the Condyle of the Temporomandibular Joint. International Journal of Molecular Sciences, 20(9), Article 2260. https://doi.org/10.3390/ijms20092260
  • Tastepe, C. S., Lin, X., Donnet, M., Doulabi, B. Z., Wismeijer, D., & Liu, Y. (2018). Re-establishment of biocompatibility of the in vitro contaminated titanium surface using osteoconductive powders with air-abrasive treatment. Journal of Oral Implantology, 44(2), 94-101. https://doi.org/10.1563/aaid-joi-D-17-00128
  • Haghiralsadat, F., Amoabediny, G., Naderinezhad, S., Forouzanfar, T., Helder, M. N., & Zandieh-Doulabi, B. (2018). Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy. Artificial Cells, Nanomedicine and Biotechnology, 46(S1), 684-692. https://doi.org/10.1080/21691401.2018.1434533
  • Haghiralsadat, F., Amoabediny, G., Helder, M. N., Naderinezhad, S., Sheikhha, M. H., Forouzanfar, T., & Zandieh-Doulabi, B. (2018). A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Artificial Cells, Nanomedicine and Biotechnology, 46(1), 169-177 . https://doi.org/10.1080/21691401.2017.1304403
  • Amoabediny, G., Haghiralsadat, F., Naderinezhad, S., Helder, M. N., Akhoundi Kharanaghi, E., Mohammadnejad Arough, J., & Zandieh-Doulabi, B. (2018). Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. International Journal of Polymeric Materials and Polymeric Biomaterials, 67(6), 383-400. https://doi.org/10.1080/00914037.2017.1332623
  • Open Access
    Haghiralsadat, F., Amoabediny, G., Naderinezhad, S., Zandieh-Doulabi, B., Forouzanfar, T., & Helder, M. N. (2018). Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted pegylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. International Journal of Nanomedicine, 13, 3853-3866. https://doi.org/10.2147/IJN.S150017
  • Haghiralsadat, F., Amoabediny, G., Sheikhha, M. H., Zandieh-doulabi, B., Naderinezhad, S., Helder, M. N., & Forouzanfar, T. (2017). New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity. Chemical Biology and Drug Design, 90(3), 368-379. https://doi.org/10.1111/cbdd.12953
  • Haghiralsadat, F., Amoabediny, G., Naderinezhad, S., Nazmi, K., de Boer, J. P., Zandieh-Doulabi, B., Forouzanfar, T., & Helder, M. N. (2017). EphA2 targeted doxorubicin-nanoliposomes for osteosarcoma treatment. Pharmaceutical Research, 34(12), 2891-2900. https://doi.org/10.1007/s11095-017-2272-6
  • Yeung, K. K., Bogunovic, N., Keekstra, N., Beunders, A. A. M., Pals, J., van der Kuij, K., Overwater, E., Wisselink, W., Blankensteijn, J. D., van Hinsbergh, V. W. M., Musters, R. J. P., Pals, G., Micha, D., & Zandieh-Doulabi, B. (2017). Transdifferentiation of Human Dermal Fibroblasts to Smooth Muscle-Like Cells to Study the Effect of MYH11 and ACTA2 Mutations in Aortic Aneurysms. Human Mutation, 38(4), 439-450. https://doi.org/10.1002/humu.23174
Page 1 of 7